The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes

References

• Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
   PubMed Web of Science ®Google Scholar
• Ackerman J. The ultimate social network. Sci. Am. 306, 36–43 (2012).
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260–270 (2012).
   PubMed Web of Science ®Google Scholar
• Pugliese A. The multiple origins of Type 1 diabetes. Diabet. Med. 30, 135–146 (2013).
   PubMed Web of Science ®Google Scholar
• Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34, 39–58 (2013).
   PubMed Web of Science ®Google Scholar
• Bäckhed F. Programming of host metabolism by the gut microbiota. Ann. Nutr. Metab. 58, 44–52 (2011).
   PubMed Web of Science ®Google Scholar
• Buccigrossi V, Nicastro E, Guarino A. Intestinal microbiota composition in children. In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 9–16 (2013).
   Google Scholar
• Robles Alonso V and Guarner F. Intestinal microbiota composition in adults. In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 17–24 (2013).
   Google Scholar
• Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
   PubMed Web of Science ®Google Scholar
• Barrett E, Dinan TG, Cryan JF et al. Effects of the intestinal microbiota on behavior and brain biochemistry. In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 56–63 (2013).
   Google Scholar
• de Goffau MC, Luopajarvi K, Knip M et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 62, 1238–1244 (2013).
   PubMed Web of Science ®Google Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 11, 46 (2013).
   PubMed Web of Science ®Google Scholar
• Beyan H, Wen L, Leslie RD. Guts, germs, and meals: the origin of type 1 diabetes. Curr. Diab. Rep. 12, 456–462 (2012).
   PubMed Web of Science ®Google Scholar
• Vaarala O. Is the origin of type 1 diabetes in the gut? Immunol. Cell Biol. 90, 271–276 (2012).
   PubMed Web of Science ®Google Scholar
• Hara N, Alkanani AK, Ir D et al. The role of the intestinal microbiota in type 1 diabetes. Clin. Immunol. 146, 112–119 (2013).
   PubMed Web of Science ®Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin. Diabetes 29, 116–122 (2011).
   Google Scholar
• Muller LM, Gorter KJ, Hak E et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin. Infect. Dis. 41, 281–288 (2005).
   PubMed Web of Science ®Google Scholar
• Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44, B3–B8 (2001).
   PubMed Web of Science ®Google Scholar
• Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373, 2027–2033 (2009).
   PubMed Web of Science ®Google Scholar
• Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun. Rev. 9, A355–A365 (2010).
   PubMed Web of Science ®Google Scholar
• Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342, d35 (2011).
   PubMed Web of Science ®Google Scholar
• Filippi C, von Herrath M. How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol. 233, 125–132 (2005).
   PubMed Web of Science ®Google Scholar
• Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J. Pediatr. 154, 132–134 (2009).
   Google Scholar
• Cooper JD, Smyth DJ, Walker NM et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 60, 1624–1631 (2011).
   PubMed Web of Science ®Google Scholar
• Knip M, Virtanen SM, Becker D, Dupre J, Krischer JP, Akerblom HK. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR). Am. J. Clin. Nutr. 94, 1814S–1820S (2011).
   Google Scholar
• Patelarou E, Girvalaki C, Brokalaki H, Patelarou A, Androulaki Z, Vardavas C. Current evidence on the associations of breastfeeding, infant formula, and cow’s milk introduction with type 1 diabetes mellitus: a systematic review. Nutr. Rev. 70, 509–519 (2012).
   PubMed Web of Science ®Google Scholar
• Kukreja A, Maclaren NK. Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes. Cell Mol. Life Sci. 57, 534–541 (2000).
   PubMedGoogle Scholar
• Patrick C, Wang GS, Lefebvre DE et al. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide. Diabetes 62, 2036–2047 (2013).
   PubMed Web of Science ®Google Scholar
• Stene LC, Gale EA. The prenatal environment and type 1 diabetes. Diabetologia 56(9), 1888–1897 (2013).
   Google Scholar
• Todd JA. Etiology of type 1 diabetes. Immunity 32, 457–467 (2010).
   PubMed Web of Science ®Google Scholar
• Biason-Lauber A, Boni-Schnetzler M, Hubbard BP et al. Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab. 17, 448–455 (2013).
   PubMed Web of Science ®Google Scholar
• Giongo A, Gano KA, Crabb DB et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5, 82–91 (2011).
   PubMed Web of Science ®Google Scholar
• Cebula A, Seweryn M, Rempala GA et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 497, 258–262 (2013).
   PubMed Web of Science ®Google Scholar
• Romano-Keeler J, Weitkamp JH, Moore DJ. Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 19, 73–80 (2012).
   Google Scholar
• Sonier B, Patrick C, Ajjikuttira P, Scott FW. Intestinal immune regulation as a potential diet modifiable feature of gut inflammation and autoimmunity. Int. Rev. Immunol. 28, 414–445 (2009).
   PubMed Web of Science ®Google Scholar
• Johansson ME, Ambort D, Pelaseyed T et al. Composition and functional role of the mucus layers in the intestine. Cell Mol. Life Sci. 68, 3635–3641 (2011).
   PubMed Web of Science ®Google Scholar
• Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol. Life Sci. 70, 631–659 (2013).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Madsen K, Spiller R, Greenwood-Van MB, Verne GN. Intestinal barrier function in health and gastrointestinal disease. J. Neurogastroenterol. Motil. 24, 503–512 (2012).
   PubMed Web of Science ®Google Scholar
• Su LF, Kidd BA, Han A, Kotzin JJ, Davis MM. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 38, 373–383 (2013).
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455, 1109–1113 (2008).
   PubMed Web of Science ®Google Scholar
• Hemmi H, Akira S. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86, 120–135 (2005).
   PubMedGoogle Scholar
• Alam C, Bittoun E, Bhagwat D et al. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 54, 1398–1406 (2011).
   PubMed Web of Science ®Google Scholar
• King C, Sarvetnick N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS ONE 6, e17049 (2011).
   PubMedGoogle Scholar
• Markle JG, Frank DN, Mortin-Toth S et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084–1088 (2013).
   PubMed Web of Science ®Google Scholar
• Calcinaro F, Dionisi S, Marinaro M et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48, 1565–1575 (2005).
   PubMed Web of Science ®Google Scholar
• Valladares R, Sankar D, Li N et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE 5, e10507 (2010).
   PubMed Web of Science ®Google Scholar
• Petrovsky N. Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus. Nat. Rev. Endocrinol. 6, 131–138 (2010).
   Google Scholar
• Harrison LC. Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunol. Cell Biol. 86, 139–145 (2008).
   PubMedGoogle Scholar
• Rijkers GT, Mulder L, Rombouts FM, Akkermans LMA. What is the future for therapies derived from the microbiome (pharmabiotics)? In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 186–196 (2013).
   Google Scholar
• Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070–11075 (2005).
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
   PubMed Web of Science ®Google Scholar
• Schwiertz A, Taras D, Schafer K et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver. Spring) 18, 190–195 (2010).
   PubMed Web of Science ®Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).
   PubMed Web of Science ®Google Scholar
• Qin J, Li Y, Cai Z et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012).
   PubMed Web of Science ®Google Scholar
• Kobayashi KS. Shaping intestinal bacterial community by TLR and NLR signaling. In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 32–42 (2013).
   Google Scholar
• Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104, 979–984 (2007).
   PubMed Web of Science ®Google Scholar
• Jumpertz R, Le DS, Turnbaugh PJ et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 94, 58–65 (2011).
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242–249 (2012).
   PubMed Web of Science ®Google Scholar
• Power SE, Fitzgerald GF, O’Toole PW et al. Metabolic syndrome and obesity in adults. In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 103–121 (2013).
   Google Scholar
• Bjursell M, Admyre T, Goransson M et al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 300, E211–E220 (2011).
   PubMed Web of Science ®Google Scholar
• Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279–288 (2012).
   PubMed Web of Science ®Google Scholar
• Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 182, 375–387 (2013).
   PubMed Web of Science ®Google Scholar
• Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio MC. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr. Res. 32, 637–647 (2012).
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE 7, e37160 (2012).
   PubMed Web of Science ®Google Scholar
• Caesar R, Reigstad CS, Backhed HK et al. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 61, 1701–1707 (2012).
   PubMed Web of Science ®Google Scholar
• Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS ONE 8, e63983 (2013).
   Google Scholar
• Schertzer JD, Tamrakar AK, Magalhaes JG et al. NOD1 activators link innate immunity to insulin resistance. Diabetes 60, 2206–2215 (2011).
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Clerici M, Al-Attas O et al. A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes. J. Immunol. 190, 3716–3720 (2013).
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar M, Aitken JD, Carvalho FA et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228–231 (2010).
   PubMed Web of Science ®Google Scholar
• Blohmke CJ, Park J, Hirschfeld AF et al. TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. J. Immunol. 185, 7731–7738 (2010).
   Google Scholar
• Franco BE, Altagracia MM, Sanchez Rodriguez MA, Wertheimer AI. The determinants of the antibiotic resistance process. Infect. Drug Resist. 2, 1–11 (2009).
   PubMedGoogle Scholar
• Manichanh C, Reeder J, Gibert P et al. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res. 20, 1411–1419 (2010).
   PubMed Web of Science ®Google Scholar
• Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 476, 393–394 (2011).
   PubMed Web of Science ®Google Scholar
• Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int. J. Obes. (Lond.) 35, 522–529 (2011).
   PubMed Web of Science ®Google Scholar
• Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int. J. Obes. (Lond) 34, 1531–1537 (2010).
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407–415 (2013).
   PubMed Web of Science ®Google Scholar
• Vrieze A, van Nood E, Holleman F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913–916 (2012).
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
   PubMed Web of Science ®Google Scholar
• Morelli L. Probiotics: definition and taxonomy 10 years after the FAO/WHO guidelines. In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 1–8 (2013).
   Google Scholar
• Patton TJ, Guandalini S. Are probiotic effects dose-related? In: World Review of Nutrition and Dietetics (Volume 107), Probiotic Bacteria and Their Effect on Human Health and Well-Being. Guarino A, Quigley EMM, Walker WA ( Eds). Karger, Basel, 151–160 (2013).
   Google Scholar
• Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53, 100–108 (2012).
   PubMed Web of Science ®Google Scholar
• de Punder K, Pruimboom L. The dietary intake of wheat and other cereal grains and their role in inflammation. Nutrients 5, 771–787 (2013).
   PubMed Web of Science ®Google Scholar
• Roberfroid M. Prebiotics: the concept revisited. J. Nutr. 137, 830S–837S (2007).
   PubMed Web of Science ®Google Scholar
• Hvistendahl M. My microbiome and me. Science 336, 1248–1250 (2012).
   Google Scholar
• Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474–481 (2004).
   PubMed Web of Science ®Google Scholar
• Talbot K, Wang HY, Kazi H et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338 (2012).
   PubMed Web of Science ®Google Scholar
• Bomfim TR, Forny-Germano L, Sathler LB et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Abeta oligomers. J. Clin. Invest. 122, 1339–1353 (2012).
   PubMed Web of Science ®Google Scholar
• Kaisaki PJ, Delepine M, Woon PY et al. Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes 53, 1900–1904 (2004).
   PubMedGoogle Scholar
• Accardi G, Caruso C, Colonna-Romano G, Camarda C, Monastero R, Candore G. Can Alzheimer disease be a form of type 3 diabetes? Rejuvenation Res. 15, 217–221 (2012).
   Google Scholar
• Lue LF, Andrade C, Sabbagh M, Walker D. Is there inflammatory synergy in Type II diabetes mellitus and Alzheimer's disease? Int. J. Alzheimers. Dis. 2012, 918680 (2012).
   Google Scholar
• Arab L, Sadeghi R, Walker DG, Lue LF, Sabbagh MN. Consequences of aberrant insulin regulation in the brain: can treating diabetes be effective for Alzheimer’s Disease. Curr. Neuropharmacol. 9, 693–705 (2011).
   Google Scholar
• Brenner SR. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as beta-N-methylamino-l-alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horses. Med. Hypotheses 80, 103–103 (2013).
   PubMed Web of Science ®Google Scholar
• Forsythe P, Kunze WA, Bienenstock J. On communication between gut microbes and the brain. Curr. Opin. Gastroenterol. 28, 557–562 (2012).
   PubMed Web of Science ®Google Scholar
• Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A. Effects of symbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized crossover controlled clinical trial. Clin. Nutr. doi:10.1016/j.clnu.2013.05.015 (2013) ( Epub ahead of print).
   Google Scholar
• Tillisch K, Labus J, Kilpatrick L et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144, 1394–1401 (2013).
   PubMed Web of Science ®Google Scholar